To further study the mechanism of SPD alleviating DCM, we used P2X7 specific inhibitor (A-438079) and ERK1/2 signaling pathway blocker (LY3214996) to treat with cardiomyocytes separately. This evidence concerns the gene P2RX7 and familial dilated cardiomyopathy.